In this proposal we plan to further define the roles of the adapter proteins Shc and Cbl, and their associated molecules, in T cell signaling. They plan to develop a better understanding of these proteins by employing biochemical approaches, studying the function of these proteins in transformed T cells and finally studying their function in animals. I. The role of Shc in T cell activation and T cell development. They have observed that dominant negative mutants of Shc, when introduced into the murine T cell hybridoma DO. I 1, can disrupt T cell receptor (TCR) mediated IL-2 production and antigen induced cell death (AICD). They will define the Shc signaling-pathwgys by defining the proteins upstream and downstream of Shc. They will also introduce the dominant negative forms of Shc as transgenes into bone marrow stem cells to determine their effect on T cell development and T cell effector function in vivo. II. The role of Cbl in T cell activation and T cell development. Cbl appears to play a role as a negative regulator of T cell signaling. They will use a variant Jurkat cell, Jl16, which lacks ZAP-70 and Syk to define the mechanism by which Cbl inhibits T cell signaling. They will introduce mutant forms of Cbl into c-Cbl-/- mice to define its role in vivo. III. The role of SLAP and TSAD in T cell signaling. Usin2 Cbl-N as bait in the modified yeast two hybrid system they have isolated CDNA clones encoding two adapter proteins, SLAP and TSAD. They propose to study their role in T cell signaling.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA070758-06
Application #
6376252
Study Section
Experimental Immunology Study Section (EI)
Program Officer
Mccarthy, Susan A
Project Start
1996-06-04
Project End
2001-09-30
Budget Start
2001-04-01
Budget End
2001-09-30
Support Year
6
Fiscal Year
2001
Total Cost
$109,031
Indirect Cost
Name
Dana-Farber Cancer Institute
Department
Type
DUNS #
149617367
City
Boston
State
MA
Country
United States
Zip Code
02215
Alzabin, Saba; Pyarajan, Saiju; Yee, Herman et al. (2010) Hematopoietic progenitor kinase 1 is a critical component of prostaglandin E2-mediated suppression of the anti-tumor immune response. Cancer Immunol Immunother 59:419-29
Sawasdikosol, Sansana; Russo, Kristin M; Burakoff, Steven J (2003) Hematopoietic progenitor kinase 1 (HPK1) negatively regulates prostaglandin E2-induced fos gene transcription. Blood 101:3687-9
Fragoso, Roben; Ren, Dejian; Zhang, Xiaoping et al. (2003) Lipid raft distribution of CD4 depends on its palmitoylation and association with Lck, and evidence for CD4-induced lipid raft aggregation as an additional mechanism to enhance CD3 signaling. J Immunol 170:913-21
Baksh, Shairaz; Widlund, Hans R; Frazer-Abel, Ashley A et al. (2002) NFATc2-mediated repression of cyclin-dependent kinase 4 expression. Mol Cell 10:1071-81
Tkaczuk, Jean; Yu, Chao-Lan; Baksh, Shairaz et al. (2002) Effect of anti-IL-2Ralpha antibody on IL-2-induced Jak/STAT signaling. Am J Transplant 2:31-40
Yu, C L; Jin, Y J; Burakoff, S J (2000) Cytosolic tyrosine dephosphorylation of STAT5. Potential role of SHP-2 in STAT5 regulation. J Biol Chem 275:599-604
Pratt, J C; van den Brink, M R; Igras, V E et al. (1999) Requirement for Shc in TCR-mediated activation of a T cell hybridoma. J Immunol 163:2586-91
Pratt, J C; Sawasdikosol, S; van den Brink, M R et al. (1999) Positive and negative signaling pathways. Transplant Proc 31:772-4
Tang, J; Sawasdikosol, S; Chang, J H et al. (1999) SLAP, a dimeric adapter protein, plays a functional role in T cell receptor signaling. Proc Natl Acad Sci U S A 96:9775-80
Jin, Y J; Yu, C L; Burakoff, S J (1999) Human 70-kDa SHP-1L differs from 68-kDa SHP-1 in its C-terminal structure and catalytic activity. J Biol Chem 274:28301-7

Showing the most recent 10 out of 13 publications